Assessment of Zoan products as biomaterials for 3D printing in health care

Project description

3D printing using marine coral

3D printing technology is a rapid emerging technology that empowers manufacturers in the medical sector to produce customised medical equipment and products. Zoan Biomed, a dynamic SME based in the west coast of Ireland, specialises in cultivating medical-grade marine coral and creating products from it that can be used as a bone graft substitute. Zoan, through the EU-funded InnovationOrigin project aims to pen up a new realm of potential applications through the 3D printing sector. Zoan is positioning itself to enter the global 3D printing market, which was valued at USD 4.2 billion in 2014, and is projected to reach USD 44.4 billion by 2025, registering a CAGR of 21.8 % from 2019 to 2025.

Fields of science

• natural sciences › chemical sciences › catalysis
• social sciences › economics and business › business and management › employment
• engineering and technology › mechanical engineering › manufacturing engineering › additive manufacturing
• engineering and technology › industrial biotechnology › biomaterials

Programme(s)

• H2020-EU.2.3.2.2. - Enhancing the innovation capacity of SMEs

Topic(s)

• INNOSUP-02-2019-2020 - European SME innovation Associate - pilot

Call for proposal

H2020-INNOSUP-2019-02
See other projects for this call

Funding Scheme

CSA - Coordination and support action

Coordinator

ZOAN BIOMED LIMITED

Address

An Luslann Kylebroughlan Moyculle
H91 TXV5 Galway
Ireland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

EU contribution

€ 114 687,50